Vimarsana
Biggest News Aggregation in the World

Page 5 - Marie Utter News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marie Utter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marie Utter Today - Breaking & Trending Today

Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Sells 4,688 Shares of Stock - Vimarsana News

Insider Selling: PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Sells 4,688 Shares of Stock

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) CAO Christine Marie Utter sold 4,688 shares of the company’s stock in a transaction that occurred on Wednesday, March 29th. The shares were sold at an average price of $47.79, for a total value of $224,039.52. Following the sale, the chief accounting officer now owns 38,059 shares in […]

Source: wkrb13.com
Intel's (INTC) Sell Rating Reiterated at Rosenblatt Securities - Vimarsana News

Intel's (INTC) Sell Rating Reiterated at Rosenblatt Securities

Should You Buy or Sell PTC Therapeutics Stock? Get The Latest PTCT Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Christine Marie Utter Sells 26,658 Shares - Vimarsana News

PTC Therapeutics, Inc. (NASDAQ:PTCT) CAO Christine Marie Utter Sells 26,658 Shares

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) CAO Christine Marie Utter sold 26,658 shares of the firm’s stock in a transaction that occurred on Monday, March 27th. The shares were sold at an average price of $45.09, for a total transaction of $1,202,009.22. Following the completion of the transaction, the chief accounting officer now owns […]

Source: wkrb13.com
PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $52.00 Average Price Target from Analysts - Vimarsana News

PTC Therapeutics, Inc. (NASDAQ:PTCT) Receives $52.00 Average Price Target from Analysts

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) have earned a consensus rating of “Hold” from the fourteen brokerages that are presently covering the firm, MarketBeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the company. […]

PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Rating of "Hold" by Brokerages - Vimarsana News

PTC Therapeutics, Inc. (NASDAQ:PTCT) Given Consensus Rating of "Hold" by Brokerages

Shares of PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Rating) have received an average rating of “Hold” from the twelve brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and five have issued a buy recommendation on the company. […]